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ABSTRACT
Background An increasing number of sporting bodies
report unacceptably high levels of false-positive ECGs
when undertaking pre-participation cardiac screening. To
address this issue, modified ECG interpretation criteria
have become available for use within athletes.
Objective This study assessed the accuracy of the new
2014 ‘Refined Criteria’ against the 2013 Seattle Criteria
and the 2010 European Society of Cardiology (ESC)
recommendations in a cohort of Arabic, black and
Caucasian athletes.
Methods 2491 male athletes (1367 Arabic, 748 black
and 376 Caucasian) undertook pre-participation
screening including a 12-lead ECG, with further
investigation(s) upon indication.
Results Ten athletes (0.4%) were identified with
cardiac pathology; seven with hypertrophic
cardiomyopathy (HCM; five black and two Arabic) and
three Arabs with Wolff–Parkinson–White syndrome
(WPW). All three ECG criteria were 100% sensitive
identifying all cases of HCM and WPW. The 2014
Refined Criteria reduced (p<0.0001) the prevalence of
an abnormal ECG to 5.3% vs 11.6% (Seattle Criteria)
and 22.3% (2010 ESC recommendations). The 2014
Refined Criteria significantly (p<0.0001) improved
specificity (94.0%) across all ethnicities compared with
the Seattle Criteria (87.5%) and ESC recommendations
(76.6%). Black athletes continue to present a higher
prevalence (p<0.0001) of abnormal ECGs compared
with Arabic and Caucasian athletes (10% vs 3.6% and
2.1%).
Conclusions The 2014 Refined Criteria for athlete ECG
interpretation outperformed both the 2013 Seattle
Criteria and the 2010 ESC recommendations by
significantly reducing the number of false-positive ECGs
in Arabic, black and Caucasian athletes while
maintaining 100% sensitivity for serious cardiac
pathologies.
INTRODUCTION
In 2010, the European Society of Cardiology (ESC)
produced ‘revised’ recommendations for the inter-
pretation of ECGs of athletes.1 This was due to the
increasing number of sporting governing bodies
undertaking pre-participation cardiovascular
screening reporting unacceptably high levels of
false-positive ECGs arising from the overlap
between physiological ECG patterns commonly
observed in athletes and those suggestive of cardiac
pathology. To demonstrate improved specificity, the
authors reanalysed the ECGs of 1005 highly
trained athletes previously reported a decade
earlier.2 Originally, 402 athletes (40%) presented
an abnormal ECG (so-called ‘group 2’ changes),
which was lowered to 11% using the 2010 ESC
recommendations. Work from our group and
others has, however, demonstrated that certain
black ethnic populations, such as African,
African-Caribbean and Black Latin-American, con-
tinue to demonstrate a high prevalence of abnormal
ECGs (approximately 20–40%) when using the
2010 ESC recommendations.3–6
To address this issue, in 2012 an international
team of experts produced the ‘Seattle Criteria,’7
a revision of ECG interpretation guidelines for ath-
letes, aimed to provide greater accuracy in identify-
ing those with cardiac pathology, while also
attempting to reduce the false-positive rate. The
Seattle Criteria have demonstrated favourable
results over the ESC recommendations, with a
reduction in the number of ECGs previously con-
sidered abnormal (17 to 4%) in a population of
high-level athletes, while still identifying all athletes
with cardiac pathology.8 Furthermore, the Seattle
Criteria consider specific ethnic ECG facets such as
anterior (V1–V4) T-wave inversion (commonly
observed in up to 13% of black athletes4) to repre-
sent an ethnically benign variant of the athlete’s
heart in those of black ethnicity, helping to reduce
false-positive rates further.
Recently, Sheikh et al9 published additional
‘Refined Criteria’ for ECG interpretation, based
upon their experience of screening thousands of
athletes using both the ESC recommendations and
the Seattle Criteria. Sheikh et al9 demonstrated that
the ECG patterns of isolated atrial enlargement
(left and right), axis deviation (left and right) and
RV hypertrophy (RVH) found in both the ESC
recommendations and the Seattle Criteria provided
an extremely low diagnostic yield for cardiac path-
ology. A unique feature of this investigation was a
validation assessment in 103 young athletes with
confirmed hypertrophic cardiomyopathy (HCM)
whereby the Refined Criteria identified 98.1% of
HCM cases.
While the ESC guidelines were initially consid-
ered acceptable for use within Arabic athletes,3 it is
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unknown whether the Seattle Criteria or the Refined Criteria
are clinically appropriate for differentiating physiological
cardiac adaptation from inherited pathology associated with
sudden cardiac death (SCD) in Arabic athletes. Consequently,
the aim of this investigation was to assess the accuracy of the
new 2014 Refined Criteria versus the 2013 Seattle Criteria and
the 2010 ESC recommendations in a large cohort of Arabic,
black and Caucasian athletes when undertaking mass pre-
participation cardiovascular screening.
Participants
Between November 2010 and January 2014, 2491 male athletes
(exercising ≥6 h/week) presented at Aspetar Orthopaedic Sports
Medicine Hospital for pre-participation cardiac screening, of
whom 1367 were Arabic, 748 black and 376 Caucasian.
Ethnicity was self-determined by the athlete. Arabic athletes
were recruited from seven Gulf States (Qatar, Bahrain, Oman,
United Arab Emirates, Kuwait, Yemen and Saudi Arabia) and
seven Middle-Eastern countries (Egypt, Morocco, Algeria,
Tunisia, Jordan, Palestine and Lebanon). Black athletes came
from nine African countries (Sudan, Somalia, Ghana, Nigeria,
Chad, Ivory Coast, Senegal, Cameroon and Ethiopia), three
Caribbean countries (Trinidad and Tobago, Jamaica and Cuba)
and those that self-determined their ethnicity as black from
South America (Brazil, Colombia, Ecuador and Uruguay). The
vast majority of Caucasian athletes came from mainland Europe,
Australia and North America with a small number from South
America.
Pre-participation cardiovascular screening
All players were screened using a cardiovascular pre-competition
medical assessment form. Athletes completed the questionnaire
regarding family history and personal symptoms, together with
measurements of height, body mass, left brachial artery blood
pressure in collaboration with an Arabic-speaking,
French-speaking or English-speaking cardiac nurse. Precordial
auscultation in supine and standing positions, and assessment
for any physical characteristics of Marfan’s syndrome were
undertaken by a Sports Medicine Physician. From 2491 athletes
presenting for pre-participation cardiac screening, 1718 (68.7%)
required both ECG and echocardiography as standard as part of
sport or club requirements.
Resting 12-lead ECG
A 12-lead ECG was recorded on all athletes after a period of
5 min rest in the supine position using a GE Mac 5500
(New York, USA). A well-defined protocol for electrode place-
ment was used throughout by a single physiologist. Six electro-
des are placed on the chest in the following locations: V1,
fourth intercostal space at the right sternal border; V2, fourth
intercostal space at the left sternal border; V3, midway between
V2 and V4; V4, fifth intercostal space in the midclavicular line;
V5, in the horizontal plane of V4 at the anterior axillary line, or
if the anterior axillary line is ambiguous, midway between V4
and V6; and V6, in the horizontal plane of V4 at the midaxillary
line. Four limb lead electrodes were placed on the arms and legs
distal to the shoulders and hips.
Echocardiography
Echocardiographic examination was performed using a commer-
cially available ultrasound system (Philips, USA). Images of the
heart were obtained in the standard planes,10 with cardiac struc-
ture and function evaluated with previously described criteria.3
All echocardiograms were obtained and reported by a single
echocardiographer.
Further evaluation and follow-up
Athletes demonstrating symptoms, a family history of SCD, ECG
abnormalities and/or echocardiographic abnormalities consid-
ered to represent pathology, were investigated further.
Subsequent studies included 24 h ECG, maximal exercise testing
and cardiac MRI. A diagnosis of disease was established using
published criteria.11 12
Retrospective ECG examination
All 2491 ECGs were analysed retrospectively using the ESC
recommendations, followed by the Seattle Criteria and Refined
Criteria. During analysis, first and last authors were blinded to
pathological findings in all athletes, with MGW providing final
judgement on ECG normality or abnormality using each of the
three ECG criteria. Electrocardiographic parameters used to
define various ECG abnormalities for the three sets of criteria
are presented in table 1.
Refined Criteria
Differences between the ESC recommendations and the Seattle
Criteria can be observed in table 1. Compared with the ESC
recommendations and the Seattle Criteria, the unique aspect of
the Refined Criteria is that athletes would not receive further
cardiovascular evaluation when presenting with the following
recognised training-related ECG changes in isolation; (1) left
atrial enlargement (LAE), (2) right atrial enlargement (RAE), (3)
left axis deviation (LAD), (4) right axis deviation (RAD) and (5)
Sokolow–Lyon voltage criteria for RVH. In line with the Seattle
Criteria, a corrected (Bazett’s formula) QT interval (QTc)
≥470 ms in men and ≥480 ms in women, and T-wave inversion
preceded by convex ST-segment elevation in leads V1–V4 in
asymptomatic black athletes do not require further investigation.
However, importantly, the presence of two or more of the
above ECG patterns would warrant secondary investigation
(figure 1).9 It is worth noting that the Refined Criteria are not
an evolution of the 2012 Seattle Criteria, but use ECG para-
meters from both the 2010 ESC recommendations and the
Seattle Criteria.
Statistical analysis
Data were analysed using SPSS V.21.0 (Illinois, USA); presented
as mean±SD (range) and percentage where appropriate.
One-way analysis of variance using Bonferroni adjustments (if
applicable) was used to identify differences in athlete anthro-
pometry. A χ2 test was used to compare the number of abnor-
mal ECGs between the three ECG interpretation criteria and
between athlete ethnicities. Specificity and sensitivity for the
three criteria were calculated in those athletes who undertook
both ECG and echocardiography as part of club requirements,
following which positive and negative likelihood ratios were cal-
culated. A McNemar χ2 test was used to compare specificity and
positive likelihood ratios between criteria. A p value <0.05 was
considered significant.
RESULTS
Athlete demographics
Overall, Arabic athletes were younger than both black and
Caucasian athletes (21.3±5.4 vs 24.1±5.0 and 24.3±5.4 years,
respectively; p<0.05). Arabic athletes had a smaller body
surface area (BSA) than both black and Caucasian athletes
(1.87±0.26 m2 vs 2.00±0.28 m2 vs 2.14±0.26 m2, p<0.05).
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Caucasian athletes presented a larger BSA than black athletes
(p<0.05). Athletes competed in a range of competitive sports
(n=27), with four high-intensity intermittent sports dominating
participation rates (soccer (43.2%), handball (13.7%), volleyball
(9.1%) and basketball (8.5%)).
Identification of cardiac pathology
Ten athletes (0.6%) were identified with a cardiac pathology
associated with SCD; seven with HCM (five black and two
Arabic) and three Arabic athletes with Wolff–Parkinson–White
syndrome (WPW). All athletes with HCM presented with an
abnormal ECG, but were diagnosed with pathology via a com-
bination of echocardiography, 24 h Holter, exercise stress testing
and cardiac MRI. The incidence of HCM in black athletes
(0.9%) was five times greater than in Arabic athletes (0.2%). All
athletes with HCM displayed T-wave inversion; five inferolat-
eral, one isolated lateral and one with anterior-inferior. Six of
the seven HCM athletes demonstrated ‘deep’ (>0.3 mV) T-wave
inversion, ST-segment depression and Sokolow voltage criteria
for LV hypertrophy (LVH), calculated as the amplitude of the
S-wave in V1 plus the amplitude of the R-wave in either V5 or
V6 ≥3.5 mV (mean 4.53 mV). These three cases of WPW
demonstrated a classical delta wave, a short PR interval together
with a prolonged QRS duration. All three athletes underwent
electrophysiological study and ablation, returning to full compe-
tition following a 2-month postoperative recovery period.
Comparison of three ECG interpretation criteria
The number of ECGs considered abnormal using the three cri-
teria is presented in table 2. From 2491 athletes, 555 (22.3%)
were considered to have an abnormal ECG according to the
ESC recommendations. The most common ECG abnormalities
were a prolonged QT interval (26.1%), T-wave inversion
(21.3%), RAE (16.5%) and a short PR interval (12.4%). Black
athletes were significantly more likely to present an abnormal
ECG than Arabic and Caucasian athletes (29.9% vs 19.1% and
18.6%, respectively, p<0.0001).
Compared with the ESC recommendations, use of the Seattle
Criteria significantly reduced the number of abnormal ECGs
from 22.3% to 11.6% (a 48% reduction; p<0.0001). The main
two ECG parameters that accounted for the majority of this
improvement were an increase in the QTc cut-offs (≥470 ms
men and ≥480 ms women) and the acknowledgement that iso-
lated anterior T-wave inversion in asymptomatic black athletes is
benign. This spared 172 (6.9%) athletes from further investiga-
tion. From the remaining abnormal ECGs, 54.6% were consid-
ered abnormal due to either isolated RAE (31.8%), LAE
(13.1%), LAD and RAD (5.2% and 3.1%) and RVH (1.4%).
Pathological Q waves (27.0%) and other locations of T-wave
inversion (23.2%) were also highly prevalent. Black athletes
were again significantly more likely to present an abnormal
ECG than Arabic and Caucasian athletes (16.6% vs 9.7% and
8.5%, respectively, p<0.0001). Yet across all three ethnicities,
the number of abnormal ECGs was significantly reduced com-
pared with the ESC recommendations (p<0.0001).
Application of the Refined Criteria further reduced
(p<0.0001) the number of abnormal ECGs in athletes to 5.3%.
Compared with the ESC recommendations and the Seattle
Criteria, this produced a 76% and 54% reduction in the
number of abnormal ECGs, respectively. However, black
Table 1 Electrocardiographic parameters used to define various ECG abnormalities in the European Society of Cardiology recommendations,
Seattle Criteria and Refined Criteria
ECG abnormality
European Society of Cardiology (ESC)
recommendations Seattle Criteria Refined Criteria
Left atrial
enlargement
Negative portion of the P-wave in lead V1 ≥0.1 mV in
depth and ≥40 ms in duration
Prolonged P-wave duration of >120 ms in leads I or II
with negative portion of the P-wave ≥0.1 mV in depth
and ≥40 ms in duration in lead V1
As ESC
Right atrial
enlargement
P-wave amplitude ≥2.5 mm in leads II, III or aVF As ESC As ESC
Left QRS-axis
deviation
−30° to −90° As ESC As ESC
Right QRS-axis
deviation
>115° >120° As ESC
RV hypertrophy Sum of R-wave in V1 and S-wave in V5 or V6
≥1.05 mV
Sum of R-wave in V1 and S-wave in V5>1.05 mV and
right axis deviation >120O
As ESC
Corrected QT interval >440 ms (men) and >460 ms (women) >470 ms (men) and 480 ms (women) As Seattle
Complete left bundle
branch block
QRS ≥120 ms predominantly negative QRS complex in
lead V1 (QS or rS), and upright monophasic R-wave in
leads I and V6
As ESC As ESC
Complete right bundle
branch block
RSR pattern in anterior precordial leads with QRS
duration ≥120 ms
Not relevant As ESC
Intraventricular
conduction delay
Any QRS duration >120 ms including RBBB and LBBB Any QRS duration ≥140 ms or complete LBBB As ESC
Pathological Q-wave >0.4 mV deep in any lead except III, aVR >0.3 mV deep and/or >40 ms duration in ≥2 leads except
III and aVR
≥40 ms in duration or
≥25% of the height of the
ensuing R-wave
Significant T-wave
inversion
≥2 mm in ≥2 adjacent leads (deep)or ‘minor’ in ≥2
leads
>1 mm in depth in two or more leads V2−6, II and aVF
or I and aVL (excludes III, aVR and V1)
As Seattle
ST-segment
depression
≥0.5 mm deep in ≥2 leads As ESC As ESC
Ventricular
pre-excitation
PR interval <120 ms with or without delta wave PR interval <120 ms with delta wave As Seattle
LBBB, left bundle branch block; mm, millimetres; ms, milliseconds; RBBB, right bundle branch block.
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athletes continue to present a significantly higher (p<0.0001)
prevalence of abnormal ECGs compared with Arabic and
Caucasian athletes (10% vs 3.6% and 2.1%).
Sensitivity and specificity for the three ECG interpretation
criteria
From 2491 athletes screened, 1718 (68.7%) were required to
undergo both ECG and echocardiography due to club require-
ments. This cohort also contained all of the pathological cases
(seven HCM and three WPW) and was consequently used to
calculate the incidence of serious pathology together with the
sensitivity and specificity of the three ECG interpretation cri-
teria (table 3). Compared with the ESC recommendations, the
Seattle Criteria significantly improved specificity from 76.6% to
87.5%, while the Refined Criteria further improved specificity
to 94.0%. Among black athletes, the Refined Criteria offered
90.2% specificity compared with 69.5% and 83.7% for the ESC
recommendations and the Seattle Criteria, respectively. This sig-
nificant improvement in specificity was also seen in Arabic ath-
letes. The Refined Criteria led to a significant improvement in
specificity (95.6%) compared with 80.2% and 88.9% for the
ESC recommendations and the Seattle Criteria, respectively.
However, there was 100% sensitivity for all three ECG
interpretation criteria that detected all seven cases of HCM and
three cases of WPW.
DISCUSSION
The correct differentiation of physiological adaptation owing to
sustained and intensive exercise from an inherited or congenital
cardiac pathology is paramount in order to correctly identify
athletes at risk of SCD. The key finding from the current study
is that the prevalence of an abnormal ECG was significantly
reduced to 5.3% when using the 2014 Refined Criteria com-
pared with the 2013 Seattle Criteria (11.6%) and the 2010 ESC
recommendations (22.3%), respectively, while all three ECG
interpretation criteria proved 100% sensitive, identifying all
cases of serious cardiac pathology.
Our results demonstrate that when using the 2010 ESC
recommendations, almost one in five Arabic, one in three black
and one in five Caucasian athletes would require further investi-
gation due to an abnormal ECG. These high false-positive rates
certainly reinforce concerns voiced by the cardiovascular screen-
ing sceptics. While the ESC recommendations are based upon
consensus rather than scientific evidence, the Seattle Criteria
modified its ECG interpretation criteria by applying evidence
that (1) accounted for the impact of African-Caribbean ethnicity
Figure 1 Definition of an abnormal
ECG using the Refined Criteria. AV,
atrioventricular; LBBB, left bundle
branch block; LVH, LV hypertrophy; ms,
milliseconds; RBBB, right bundle
branch block; PVC, premature
ventricular contraction.
Table 2 Performance comparison of three ECG interpretation criteria (ESC recommendations vs Seattle Criteria vs Refined Criteria)
Combined
(n=2491)
Arabic
(n=1367)
Black
(n=748)
Caucasian
(n=376)
Prevalence of an abnormal ECG using ESC recommendations 555 (22.3%) 261 (19.1%) 224 (29.9%) 70 (18.6%)
Prevalence of an abnormal ECG using Seattle Criteria 289 (11.6%) 133 (9.7%) 124 (16.6%) 32 (8.5%)
Prevalence of an abnormal ECG using Refined Criteria 132 (5.3%) 49 (3.6%) 75 (10%) 8 (2.1%)
Number of identified conditions associated with SCD 10 (7 HCM; 3 WPW) 4 (2 HCM; 2 WPW) 6 (5 HCM; 1 WPW) 0
FPR when using ESC recommendations 21.9% 18.8% 29.1% 18.6%
FPR when using Seattle Criteria 11.2% 9.4% 15.8% 8.5%
FPR when using Refined Criteria 4.9% 3.3% 9.2% 2.1%
ESC, European Society of Cardiology; FPR, false-positive rate; HCM, hypertrophic cardiomyopathy; SCD, sudden cardiac death; WPW, Wolff–Parkinson–White syndrome.
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upon the electrocardiographic patterns seen in athletes4 13 14
and (2) by raising the QTc thresholds (≥470 ms men and
≥480 ms women) that would trigger further evaluation.15 16 By
incorporating these two electrocardiographic features, our study
demonstrates that 172 (6.9%) athletes would be spared further
investigation, helping to lower (p<0.0001) the prevalence of
abnormal ECGs by 48% compared with the ESC recommenda-
tions. This compares favourably with a recent investigation
involving elite Caucasian athletes from Australia.8 Our data,
however, demonstrate that almost 1 in 10 Arabic, 1 in 6 black
and 1 in 11 Caucasian athletes would still require further inves-
tigation using the Seattle Criteria, primarily due to the presence
of RAE (31.8%), LAE (13.1%), LAD (5.2%), RAD (3.1%) and
RVH (1.4%), either in isolation or in association with a recog-
nised training-related ECG change.
Using HCM, arrhythmogenic right ventricular cardiomyop-
athy (ARVC) and pulmonary hypertension populations as a
comparison group, both Zaidi et al17 and Gati et al18 have
demonstrated that in asymptomatic athletes, the presence of
RAE, LAE, LAD, RAD and RVH either in isolation or in associ-
ation with a recognised training-related ECG change correlates
extremely poorly with serious cardiac pathology. Despite this,
consensus opinion for the inclusion of these ECG parameters
in both the ESC recommendations and the Seattle Criteria
comes from the fact that these anomalies, in particular LAE,
are common ECG features in HCM. In HCM, however, they
usually coexist with multitude of other ECG abnormalities
such as T-wave inversion, Q-waves and ST-segment depres-
sion.18 Excluding these ECG parameters forms the basis of the
Refined Criteria improving specificity and reducing the preva-
lence of an abnormal ECG in our cohort to 5.3% overall.
More strikingly, the Refined Criteria significantly improved the
abnormal ECG prevalence in black athletes to just 10% (vs
29.9% ESC and 16.6% Seattle Criteria), while it was further
reduced to 3.6% and 2.1% in Arabic and Caucasian athletes,
respectively.
Table 3 Sensitivity and specificity and likelihood ratios of three ECG interpretation criteria
ESC
recommendations
Seattle
Criteria
Refined
Criteria
Combined athletes:
Arabic, black and
Caucasian
+ve ECG −ve ECG +ve ECG −ve ECG +ve ECG −ve ECG
+ve path. 10 0 +ve
path.
10 0 +ve
path.
10 0
−ve path. 400 1308 −ve
path.
213 1495 −ve
path.
102 1606
Positive predictive
value (%) (95% CI)
2.4 (1.2 to 4.4) 4.5 (2.2 to 8.1) 8.9 (4.37 to 15.81)
Sensitivity (%)
(95% CI)
100 (69.0 to 100) 100 (69.0 to 100) 100 (69.0 to 100)
Specificity (%)
(95% CI)
76.6 (74.5 to 78.6) 87.5* (85.9 to 89.1) 94.0*†
(92.8 to 95.1)
Positive likelihood
ratio
(95% CI)
4.3 (3.9 to 4.7) 8.0* (7.1 to 9.1) 16.8*† (13.9 to 20.2)
Black athletes +ve ECG −ve ECG +ve ECG −ve ECG +ve ECG −ve ECG
+ve path. 6 0 +ve
path.
6 0 +ve
path.
6 0
−ve path. 168 383 −ve
path.
90 461 −ve
path.
54 497
Positive predictive
value (%) (95% CI)
3.4 (1.3 to 7.4) 6.2 (2.3 to 13.1) 10 (3.8 to 20.5)
Sensitivity (%)
(95% CI)
100 (54.1 to 100) 100 (54.1 to 100) 100 (54.1 to 100)
Specificity (%)
(95% CI)
69.5 (65.5 to 73.3) 83.7 (80.3 to 86.7)* 90.2 (87.4 to 92.5)*†
Positive likelihood
ratio
(95% CI)
3.3 (1.8 to 3.6) 6.1 (3.2 to 7.1)* 10.2 (5.3 to 12.5)*†
Arabic athletes +ve ECG −ve ECG +ve ECG −ve ECG +ve ECG −ve ECG
+ve path. 4 0 +ve
path.
4 0 +ve
path.
4 0
−ve path. 185 750 −ve
path.
104 831 −ve
path.
41 894
Positive predictive
value (%) (95% CI)
2.1 (0.6 to 5.3) 3.7 (1.0 to 9.2) 8.9 (2.5 to 21.2)
Sensitivity (%)
(95% CI)
100 (39.8 to 100) 100 (39.8 to 100) 100 (39.8 to 100)
Specificity (%)
(95% CI)
80.2 (75.6 to 82.7) 88.9* (86.7 to 90.8) 95.6*† (94.1 to 96.8)
Positive likelihood
ratio
(95% CI)
5.1 (12.2 to 5.4) 9.0* (3.8 to 10.1) 22.8*† (9.4 to 28.8)
*Significantly different from ESC recommendations.
†Significantly different from Seattle Criteria.
ESC, European Society of Cardiology; +ve ECG, abnormal ECG; −ve ECG, normal ECG; +ve path., identified cardiac pathology; −ve path., no identified cardiac pathology.
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Identification of pathology
Our study identified seven athletes (0.4%) with HCM, with the
prevalence in black athletes five times greater than Arabic athletes
(0.9% vs 0.2%). No Caucasian athlete was diagnosed with
HCM. HCM is cited as the leading cause of sudden death in
young athletes,19 particularly within the black population.20
Importantly, all three ECG interpretation guidelines identified all
seven HCM athletes with 100% sensitivity. Our incidence rates
in the present study from a cohort of 1718 athletes who under-
went systematic ECG and echocardiography are similar to those
reported in previous screening studies involving black and Arabic
athletes, who report a disease incidence of 1% and 0.5%,
respectively.6 While the incidence of HCM in black athletes is
still approximately nine times higher than that observed in
Caucasian athletes, our Arabic athletes now report similar HCM
incidence rates to that of Caucasians, estimated at 0.1%.21
A further 29 (1.2%) athletes were identified as having a con-
genital/valvular abnormality. Specifically, bicuspid aortic valve
(n=7, 0.3%), mitral valve prolapse (n=3, 0.1%), mild aortic
regurgitation (n=5, 0.2%), mitral regurgitation (mild) (n=2,
0.1%), atrial septal defect (n=6, 0.2%) and one case of dextro-
cardia (0.04%); all picked up through auscultation. None of
these athletes was restricted from competition. Only one of
these cases was identified via an abnormal ECG (dextrocardia).
This poor sensitivity underscores the importance of a physical
examination within the cardiovascular screening remit.
Limitations
Our results are based on observational cross-sectional data. The
potential for a false-negative result exists even though 90–95%
of individuals with HCM and 80% with ARVC exhibit ECG
abnormalities.22 23 Furthermore, without serial examination
over many years, it is near impossible to ascertain whether
asymptomatic athletes without a family history of SCD present-
ing with isolated LAD/RAD or LAE/RAE would later go on to
develop a cardiomyopathy. Second, our population was exclu-
sively men, limiting the application of our data to the female
athletic population.
In the present study, one athlete, a 27-year-old black football
player from South America, died unexpectedly. At the time of
pre-participation screening, the athlete reported no cardiovascu-
lar symptoms and no family history of SCD. ECG and echocar-
diography were strictly normal. The athlete self-presented to the
emergency department complaining of severe abdominal pain
and died several hours later. An autopsy was performed, but the
report has not been made available to the authors.
CONCLUSION
The 2014 Refined Criteria outperformed both the 2013 Seattle
Criteria and the 2010 ESC recommendations by significantly
reducing the number of false-positive ECGs in Arabic, black and
Caucasian male athletes while remaining 100% sensitive in iden-
tifying all athletes with cardiac pathology associated with SCD.
The 2014 Refined Criteria can not only be successfully applied
to black and Caucasian athletes, but also to Arabic athletes,
helping to reduce both further investigation rates and the poten-
tial for unnecessary disqualifications, while maintaining sensitiv-
ity for conditions that may predispose athletes to SCD.
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